Flora Rozhansky

  • Citations Per Year
Learn More
BACKGROUND The authors investigated whether prostate-specific antigen (PSA) velocity was associated significantly with the time to death after randomization among patients with hormone-refractory metastatic prostate carcinoma (HRMPC) who were treated with cytotoxic, cytotatic, or combination therapy. METHODS The study cohort included 213 men with HRMPC(More)
  • 1